Norpace CR

See also: Generic Norpace

Norpace CR is a brand name of disopyramide, approved by the FDA in the following formulation(s):

NORPACE CR (disopyramide phosphate - capsule, extended release; oral)

• 
  Manufacturer: GD SEARLE LLC
  
  Approval date: July 20, 1982
  
  Strength(s): EQ 100MG BASE, EQ 150MG BASE ^[RLD][AB]

Has a generic version of Norpace CR been approved?

Yes. The following products are equivalent to Norpace CR:

disopyramide phosphate capsule, extended release; oral

• 
  Manufacturer: NESHER PHARMS
  
  Approval date: December 15, 1987
  
  Strength(s): EQ 150MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Norpace CR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Norpace CR.

See also...

• Norpace CR Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Norpace CR Consumer Information (Cerner Multum)
• Norpace CR Advanced Consumer Information (Micromedex)
• Disopyramide Consumer Information (Wolters Kluwer)
• Disopyramide Sustained-Release Capsules Consumer Information (Wolters Kluwer)
• Disopyramide Consumer Information (Cerner Multum)
• Disopyramide Advanced Consumer Information (Micromedex)
• Disopyramide Phosphate AHFS DI Monographs (ASHP)